Global Pancreatic Cancer Market 2014-2018

Published: Oct 2014 Pages: 97 SKU: IRTNTR4314

Global pancreatic cancer market forecast

Pancreatic cancer is malignant cells form in the tissues of the pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine pancreatic cancer. When pancreatic cancer cells spread from the pancreas to other parts of the body, it is known as a metastatic pancreatic order. The incidence and mortality rate of pancreatic cancer is higher in men than in women. SEER estimates that there were 46,420 new pancreatic cancer cases recorded in the US in 2014. It also estimated that 39,590 deaths occurred in the US in 2014 as a result of pancreatic cancer, accounting for 6.8 percent of the total cancer deaths in the US. According to the pancreatic cancer market analysis, Technavio's analysts forecast the global pancreatic cancer market to grow at a CAGR of 10.70 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the global pancreatic cancer market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various drugs administered to treat different types of pancreatic cancer. The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the global pancreatic cancer market. In addition, it discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors. Technavio's report, the global pancreatic cancer market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the global pancreatic cancer market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC 
• EMEA

Key Vendors
• Celgene
• Eli Lilly
• F. Hoffmann-La Roche
• Novartis
• Pfizer

Other Prominent Vendors
 • AbGenomics International
• AB Science
• Aduro Biotech
• Aphios
• Celsion
• Gilead Sciences
• Halozyme Therapeutics
• Merrimack Pharmaceuticals
• Momenta Pharmaceuticals
• OncoMed Pharmaceuticals
• Oncozyme Pharma
• Ostuka Holdings
• Rexahn Pharmaceuticas
• Zeria Pharmaceutica

Market Driver
• Unmet Medical Need
• For a full, detailed list, view our report

Market Challenge
• High Recurrent Rates
• For a full, detailed list, view our report

Market Trend
• Use of Combination Therapies
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Technavio also provides customized reports based on the specific requirements of our clients.

 

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Therapy
07.1.1 Chemotherapy
07.1.2 Targeted Therapy
08. Geographical Segmentation
08.1 Pancreatic Cancer Market in the US
08.2 Pancreatic Cancer market in the 5EU
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors and Future Vendors
17. Key Vendor Analysis
17.1 Celgene
17.1.1 Key Facts
17.1.2 Business Description
17.1.3 Business Strategy
17.1.4 Business Segmentation by Revenue 2011-2013
17.1.5 Sales by Geography
17.1.6 Key Developments
17.1.7 SWOT Analysis
17.2 Eli Lilly
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Sales by Geography
17.2.6 Business Strategy
17.2.7 Key Developments
17.2.8 SWOT Analysis
17.3 F. Hoffmann-La Roche
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation by Revenue 2013
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Geographical Segmentation by Revenue 2013
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
17.4 Novartis
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation by Revenue 2013
17.4.4 Business Segmentation by Revenue 2012 and 2013
17.4.5 Sales by Geography
17.4.6 Business Strategy
17.4.7 Key Developments
17.4.8 SWOT Analysis
17.5 Pfizer
17.5.1 Key Facts
17.5.2 Business Description
17.5.3 Business Segmentation
17.5.4 Revenue by Business Segmentation
17.5.5 Revenue Comparison 2012 and 2013
17.5.6 Sales by Geography
17.5.7 Business Strategy
17.5.8 Key Developments
17.5.9 SWOT Analysis
18. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis